Next Generation News and Research

RSS

Covidien's PCOx mesh receives U.S. FDA 510(k) clearance and European CE Mark approval

Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance and the European regulatory authorities have granted the CE Mark to Parietex Optimized Composite mesh.

2 Jun 2011

McMaster, Abbott create new education chair to focus on rheumatology

Abbott, a global, broad-based health care company, and the Michael G. DeGroote School of Medicine at McMaster University today announced the creation of an endowed chair to focus on teaching the next generation of rheumatologists for the growing number of Canadians living with arthritis.

1 Jun 2011

MMRGlobal, VZJ to launch consumer and professional health IT products

MMRGlobal, Inc. and VisiInc PLC have entered into an agreement to launch MMRGlobal's patented consumer and professional health IT products and services, including MMRPro for healthcare professionals and the MyMedicalRecords Personal Health Record (PHR), on the Visi platform utilizing the Vistime product.

1 Jun 2011

Lymphoma vaccine extends disease-free survival by 14 months

A lymphoma vaccine uniquely tailored for each patient extends disease-free survival by 14 months, with signs of an even better response for patients with a specific biological marker, a team led by scientists at The University of Texas MD Anderson Cancer Center reported today in the online version of Journal of Clinical Oncology.

1 Jun 2011

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

CrystalGenomics, Inc. and CG Pharmaceuticals, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced that the first patient has been enrolled for a Phase 2b clinical study of CG100649, CrystalGenomics' clinical stage novel NSAID candidate, in patients with knee or hip osteoarthritis.

1 Jun 2011

EPO awards Trilink patent for CleanAmp Primers

TriLink BioTechnologies, Inc., a leader in manufacturing high quality oligonucleotides and nucleoside triphosphates, announced today the award of their CleanAmp Primer patent by the European Patent Office (EPO Patent no. 2032714).

27 May 2011

Life Technologies launches new genomic analysis software

Addressing the issue of data overload from next-generation sequencers, Life Technologies Corporation today launched its LifeScope 2.0 Genomic Analysis Software, a significantly enhanced bioinformatics system for analyzing data from genomic sequencing instruments to study human disease such as cancer.

27 May 2011

Comprehensive insight into current neural stem cell research and therapies

A new article published by Cell Press in the May 26 issue of the journal Neuron provides comprehensive insight into the current status of neural stem cell research and the sometimes labyrinthine pathways leading to stem cell-based therapies.

26 May 2011

Comtex SmarTrend ranks POZEN as second most efficient pharmaceutical company

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today that Comtex SmarTrend has ranked POZEN as the second most efficient company in the pharmaceutical industry.

25 May 2011

UA, Sandia Labs to collaborate on engineering aspects of four critical environmental research areas

The University of Arizona and Sandia National Laboratories have agreed to collaborate on engineering aspects of four critical environmental research areas in a new partnership that will initially focus on research involving management of these resources in the Southwestern U.S.

25 May 2011

Imec, Wipro create joint initiative to develop nanoelectronics and NEMS-based solutions

Imec today announced the establishment of imec India in Bangalore, Karnataka, making a first step towards the Indian market with the signing of an R&D partnership agreement with Wipro Technologies, the Global Information Technology, Consulting and Outsourcing business of Wipro Limited.

25 May 2011

MIT, ADI partner to research and develop technologies for next-generation patient monitoring devices

Analog Devices, Inc., a global leader in high-performance semiconductors for signal-processing applications and long-time supplier to the medical equipment industry, today announced a collaboration with the Massachusetts Institute of Technology to research and develop technologies for next-generation patient monitoring devices.

25 May 2011

MIT, GE partner to create Medical Electronic Device Realization Center

Supporting its quest through healthymagination to reach more patients with better health care globally, GE has joined with the Massachusetts Institute of Technology (MIT) to create a Medical Electronic Device Realization Center at MIT.

25 May 2011

Sectra's net sales increase 7.4% to SEK 910.9 million for 2010/2011 fiscal year

The IT and medical-technology company Sectra's net sales rose 7.4% to SEK 910.9 million for the 2010/2011 fiscal year, due to increased transactions with existing customers and breakthroughs in new countries.

24 May 2011

Micromet's blinatumomab data to be presented at two upcoming medical meetings

Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that data on its lead product candidate blinatumomab will be reported at two upcoming medical meetings.

23 May 2011

McDonald's reacts to protests and calls to fire Ronald

McDonald's Corp has refused to pay heed to the protesters who ask it to assess the impact of its food on childhood obesity, and said its trademark clown Ronald McDonald would be hawking Happy Meals to kids for years to come.

22 May 2011

Golden Helix integrates CMC and KBAC methods of analyzing rare DNA sequence variants in SVS product

Though two of the best-known methods for analyzing rare variants in sequencing data were published in 2008 and 2010, they have never been available to the public as a supported package.

21 May 2011

Curcumin compound can help head and neck cancer cells overcome resistance to chemotherapy drugs

A primary reason that head and neck cancer treatments fail is the tumor cells become resistant to chemotherapy drugs. Now, researchers at the University of Michigan Comprehensive Cancer Center have found that a compound derived from the Indian spice curcumin can help cells overcome that resistance.

20 May 2011

$Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma$

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced updated results from the Phase 2b 003-A1 study of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma. Carfilzomib achieved a clinical benefit rate (CBR) (minimal response or greater) in the study population of 37 percent with a duration of response (DOR) of 8.3 months.

20 May 2011

A new gene expression analysis technique on a single molecule sequencer

A new gene expression technique adapted for single molecule sequencing has enabled researchers at the RIKEN Omics Science Center (OSC) to accurately and quantitatively measure gene expression levels using only 100 nanograms of total RNA. The technique, which pairs RIKEN's Cap Analysis of Gene Expression (CAGE) protocol with the Helicos(R) Genetic Analysis System developed by Helicos BioSciences Corporation, opens the door to the detailed analysis of gene expression networks and rare cell populations. In recent years, next-generation DNA sequencers have produced an increasingly detailed picture of how genes are expressed at the molecular level. The transcriptional output of these genes - the RNA copies produced from DNA - has revealed a richness of complexity in transcript structure and function, providing insights into the molecular-level properties of cancers and other diseases.

19 May 2011